Intech Investment Management LLC lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 57.6% in the third quarter, Holdings Channel reports. The firm owned 35,313 shares of the company’s stock after selling 47,972 shares during the period. Intech Investment Management LLC’s holdings in Acadia Healthcare were worth $874,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Allworth Financial LP lifted its stake in shares of Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after acquiring an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Hantz Financial Services Inc. lifted its position in shares of Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after buying an additional 1,822 shares during the last quarter. Quent Capital LLC acquired a new position in Acadia Healthcare in the third quarter valued at approximately $71,000. Finally, Steward Partners Investment Advisory LLC increased its position in Acadia Healthcare by 639.5% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock worth $77,000 after buying an additional 2,916 shares during the period.
Wall Street Analysts Forecast Growth
Several research firms recently commented on ACHC. Barclays raised their target price on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. KeyCorp cut their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd. Zacks Research raised Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday. Royal Bank Of Canada increased their target price on Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, February 26th. Finally, Jefferies Financial Group lowered shares of Acadia Healthcare to a “hold” rating in a research note on Thursday, January 22nd. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus price target of $21.15.
Acadia Healthcare Trading Up 3.9%
Shares of Acadia Healthcare stock opened at $25.62 on Monday. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $31.43. The firm has a market capitalization of $2.36 billion, a PE ratio of -2.10, a price-to-earnings-growth ratio of 8.66 and a beta of 0.73. The company’s fifty day moving average price is $15.80 and its two-hundred day moving average price is $18.65. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.55.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter last year, the company posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
See Also
- Five stocks we like better than Acadia Healthcare
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
